- Home
- TARA vs INFU Comparison
TARA vs INFU Comparison
Compare TARA & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- INFU
- Stock Information
- Founded
- TARA N/A
- INFU 2005
- Country
- TARA United States
- INFU United States
- Employees
- TARA N/A
- INFU 514
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- INFU Medical/Dental Instruments
- Sector
- TARA Health Care
- INFU Health Care
- Exchange
- TARA Nasdaq
- INFU Nasdaq
- Market Cap
- TARA 196.8M
- INFU 211.6M
- IPO Year
- TARA N/A
- INFU N/A
- Fundamental
- Price
- TARA $5.12
- INFU $10.33
- Analyst Decision
- TARA Strong Buy
- INFU Strong Buy
- Analyst Count
- TARA 6
- INFU 2
- Target Price
- TARA $19.80
- INFU $13.50
- AVG Volume (30 Days)
- TARA 455.2K
- INFU 175.8K
- Earning Date
- TARA 11-03-2025
- INFU 11-04-2025
- Dividend Yield
- TARA N/A
- INFU N/A
- EPS Growth
- TARA N/A
- INFU 2168.02
- EPS
- TARA N/A
- INFU 0.24
- Revenue
- TARA N/A
- INFU $139,886,000.00
- Revenue This Year
- TARA N/A
- INFU $9.02
- Revenue Next Year
- TARA N/A
- INFU $6.73
- P/E Ratio
- TARA N/A
- INFU $43.65
- Revenue Growth
- TARA N/A
- INFU 8.13
- 52 Week Low
- TARA $2.21
- INFU $4.61
- 52 Week High
- TARA $10.48
- INFU $11.04
- Technical
- Relative Strength Index (RSI)
- TARA 56.48
- INFU 56.75
- Support Level
- TARA $4.96
- INFU $9.96
- Resistance Level
- TARA $5.39
- INFU $10.87
- Average True Range (ATR)
- TARA 0.30
- INFU 0.47
- MACD
- TARA -0.10
- INFU 0.07
- Stochastic Oscillator
- TARA 20.00
- INFU 71.36
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.